PFE logo

PFE
Pfizer Inc

106,045
Mkt Cap
$153.36B
Volume
66.81M
52W High
$27.94
52W Low
$20.92
PE Ratio
19.90
PFE Fundamentals
Price
$26.97
Prev Close
$27.41
Open
$27.41
50D MA
$26.63
Beta
0.41
Avg. Volume
47.21M
EPS (Annual)
$1.36
P/B
1.77
Rev/Employee
$834,386.67
$196,372.70
Loading...
Loading...
News
all
press releases
Wilsey Asset Management Inc. Has $29.77 Million Stock Holdings in Pfizer Inc. $PFE
Wilsey Asset Management Inc. lifted its stake in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 8.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·3h ago
News Placeholder
More News
News Placeholder
BCGM Wealth Management LLC Takes Position in Pfizer Inc. $PFE
BCGM Wealth Management LLC bought a new position in Pfizer Inc. (NYSE:PFE - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 49,218 shares of the biopharmaceutical company's stock...
MarketBeat·7h ago
News Placeholder
Why Pfizer (PFE) Dipped More Than Broader Market Today
In the closing of the recent trading day, Pfizer (PFE) stood at $26.97, denoting a -1.61% move from the preceding trading day.
Zacks·17h ago
News Placeholder
Pfizer (NYSE:PFE) Stock Price Down 1.6% - Should You Sell?
Pfizer (NYSE:PFE) Stock Price Down 1.6% - Here's Why...
MarketBeat·18h ago
News Placeholder
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC (Tutanota) to purchase up to 1 million shares of Pfizer common stock at a price...
Business Wire·19h ago
News Placeholder
LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D
Eli Lilly reports strong Phase III results for retatrutide in type 2 diabetes, with significant A1C reduction and up to 16.8% weight loss in the latest study.
Zacks·20h ago
News Placeholder
Top Pharmaceutical Stocks To Follow Today - March 20th
Eli Lilly and Company, AbbVie, Novo Nordisk A/S, Pfizer, and Abbott Laboratories are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical...
MarketBeat·22h ago
News Placeholder
PFE Talzenna Combo Shows Strong Efficacy in Wider Prostate Cancer Use
Pfizer's Talzenna/Xtandi combo meets phase III goals, significantly delaying disease progression in HRR-mutated metastatic castration-sensitive prostate cancer patients.
Zacks·1d ago
News Placeholder
CIBC Private Wealth Group LLC Sells 421,571 Shares of Pfizer Inc. $PFE
CIBC Private Wealth Group LLC reduced its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 46.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·1d ago
News Placeholder
Pfizer vs Moderna: Which Pharma Stock Has More Upside?
Key PointsThe smaller, more volatile of these two companies has higher potential for significant gains...
Nasdaq News: Markets·2d ago
<
1
2
...
>

Latest PFE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.